MedPath

TWYNSTA

TWYNSTA

Approved
DIN Number

02371049

Drug Class

Human

Market Date

Aug 11, 2011

Company
HC

boehringer ingelheim (canada) ltd ltee

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02371049
AIG Number0252947003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DB04 TELMISARTAN AND AMLODIPINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:28.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

AMLODIPINE (AMLODIPINE BESYLATE)Active
Strength: 5 MG
Monograph: AMLODIPINE (AMLODIPINE BESYLATE)
TELMISARTANActive
Strength: 80 MG
Monograph: TELMISARTAN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.